Types segmentation further refines the market by protein origin and functional class. Plant‑based proteins, derived from soy, peas, and legumes, capture the largest portion of the segment because they address consumer demand for sustainable, allergen‑controlled ingredients; they also enable cost‑effective scale‑up, contributing significantly to market volume. Microbial proteins, produced via fermentation of bacteria, yeast, or fungi, are gaining traction for their rapid production cycles and customizable amino‑acid profiles, especially in high‑protein snacks and feed additives. Enzyme proteins, a distinct class, are valued for catalytic efficiency in food processing, detergents, and bio‑manufacturing, driving premium pricing in niche applications. Bioactive peptides, generated through enzymatic hydrolysis, offer health‑related functionalities such as antihypertensive or antioxidant effects, expanding their use in nutraceuticals and functional beverages. Recombinant proteins, engineered through genetic expression systems, dominate the pharmaceutical and diagnostic sub‑markets due to their high specificity and regulatory acceptance. Each type contributes uniquely to the overall market size, with plant‑based and microbial proteins providing bulk volume, while enzymes, peptides, and recombinant proteins deliver higher margin growth within the Speciality Proteins market taxonomy.
